Track China Reform Health Management and Services Group , Ltd.'s EBIT ($-410M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
The latest EBIT for 000503.SZ is $-410M as of June 2026. That compares with $-190M in the prior-year period — down 117.2% year over year. That is below the sector sector average of $2.6T. Investors often review this figure alongside China Reform Health Management and Services Group , Ltd.'s historical trend and sector peers before judging valuation or financial health.
Over the past year, 000503.SZ's EBIT moved from $-190M to $-410M — a 117.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in China Reform Health Management and Services Group , Ltd.'s operating scale or balance-sheet position.
Against its sector companies, 000503.SZ currently prints $-410M for EBIT, while the sector average sits near $2.6T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at China Reform Health Management and Services Group , Ltd.'s growth, margins, and balance sheet.
A EBIT figure of $-410M for 000503.SZ is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.6T. Explore the charts below for those layers of context.
After noting 000503.SZ's EBIT ($-410M), review year-over-year change from $-190M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.